Literature DB >> 62809

Maintenance of hyporesponsiveness to antigen by a distinct subclass of T lymphocytes.

S Weitzman, F W Shen, H Cantor.   

Abstract

Immunization with increasing doses of SRBC, in excess of 10(8), results in a progressive decline in the anti-SRBC PFC response. This hyporesponsive state is antigen specific and is reflected in a decrease of both T helper and B antibody-forming activity. We asked whether the apparent defect of T helper activity reflected a) an absence of alphaSRBC helper T cell activity, or b) the presence of SRBC-specific suppressor T cells within the hyporesponsive population. Our results indicate that at least a portion of hyporesponsiveness noted after antigen exposure to large doses of antigen can be ascribed to specific suppressor T cell activation. Fractionation of the suppressive T cell population using Ly antiserum showed that specific suppressive activity was mediated by a subclass of T cells (Ly2+), distinct from that committed to express helper function (Ly1).

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 62809

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  Histamine 2 receptor-mediated immunomodulation in the mouse. I. Immunomodulation by the H2 agonist tolazoline.

Authors:  H Van Dijk; M Rapis; H E Jacobse-Geels; J M Willers
Journal:  Clin Exp Immunol       Date:  1979-03       Impact factor: 4.330

2.  Expression of Ly 1, Ly 2, Thy 1, and TL differentiation antigens on mouse T-cell tumors.

Authors:  B J Mathieson; P S Campbell; M Potter; R Asofsky
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

3.  Immunoregulatory circuits among T-cell sets. II. Physiologic role of feedback inhibition in vivo: absence in NZB mice.

Authors:  H Cantor; L McVay-Boudreau; J Hugenberger; K Naidorf; F W Shen; R K Gershon
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

4.  Ly phenotype and mechanism of action of mouse neonatal suppressor T cells.

Authors:  D E Mosier; B J Mathieson; P S Campbell
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.